Safety and tolerability of escalating cannabinoid doses in healthy cats

por Kulpa, Justyna E, Paulionis, Lina J, Eglit, Graham ML, Vaughn, Dana M
Publicado 2021

A randomized, double-blind, placebo-controlled, repeated-dose pilot study of the safety, tolerability, and preliminary effects of a cannabidiol (CBD)- and cannabigerol (CBG)-based...

por Peters, Erica N., Yardley, Helena, Harrison, Amy, Eglit, Graham M.L., Antonio, Jose, Turcotte, Cynthia, Bonn-Miller, Marcel O.
Publicado 2023

Higher cerebrospinal fluid tau is associated with history of traumatic brain injury and reduced processing speed in Vietnam‐era veterans: A Department of Defense Alzheimer's Diseas...

por Clark, Alexandra L., Weigand, Alexandra J., Bangen, Katherine J., Thomas, Kelsey R., Eglit, Graham M.L., Bondi, Mark W., Delano‐Wood, Lisa
Publicado 2021

Authorization Patterns, Safety, and Effectiveness of Medical Cannabis in Quebec

por Kalaba, Maja, MacNair, Laura, Peters, Erica N., Eglit, Graham M.L., Rapin, Lucile, Hage, Cynthia El, Prosk, Erin, Ware, Mark A.
Publicado 2021

Cognitive Practice Effects Delay Diagnosis; Implications for Clinical Trials

por Sanderson-Cimino, Mark, Elman, Jeremy A., Tu, Xin M., Gross, Alden L., Panizzon, Matthew S., Gustavson, Daniel E., Bondi, Mark W., Edmonds, Emily C., Eglit, Graham M.L., Eppig, Joel S., Franz, Carol E., Jak, Amy J., Lyons, Michael J., Thomas, Kelsey R., Williams, McKenna E., Kremen, William S.
Publicado 2020

Cognitive practice effects delay diagnosis of MCI: Implications for clinical trials

por Sanderson‐Cimino, Mark, Elman, Jeremy A., Tu, Xin M., Gross, Alden L., Panizzon, Matthew S., Gustavson, Daniel E., Bondi, Mark W., Edmonds, Emily C., Eglit, Graham M.L., Eppig, Joel S., Franz, Carol E., Jak, Amy J., Lyons, Michael J., Thomas, Kelsey R., Williams, McKenna E., Kremen, William S.
Publicado 2022